JP2024543198A5 - - Google Patents
Info
- Publication number
- JP2024543198A5 JP2024543198A5 JP2024532463A JP2024532463A JP2024543198A5 JP 2024543198 A5 JP2024543198 A5 JP 2024543198A5 JP 2024532463 A JP2024532463 A JP 2024532463A JP 2024532463 A JP2024532463 A JP 2024532463A JP 2024543198 A5 JP2024543198 A5 JP 2024543198A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- disorder
- sleep
- parkinson
- cns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111069990.0 | 2021-09-13 | ||
| CN202111069990 | 2021-09-13 | ||
| PCT/CN2022/113807 WO2023035913A1 (en) | 2021-09-13 | 2022-08-22 | Methods of treating cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543198A JP2024543198A (ja) | 2024-11-19 |
| JP2024543198A5 true JP2024543198A5 (https=) | 2025-08-27 |
Family
ID=85506085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532463A Pending JP2024543198A (ja) | 2021-09-13 | 2022-08-22 | 中枢神経障害を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250032465A1 (https=) |
| EP (1) | EP4419101A4 (https=) |
| JP (1) | JP2024543198A (https=) |
| CN (2) | CN116490180B (https=) |
| AU (1) | AU2022342095A1 (https=) |
| CA (1) | CA3239065A1 (https=) |
| IL (1) | IL313097A (https=) |
| WO (1) | WO2023035913A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023244611A1 (en) * | 2022-06-13 | 2023-12-21 | Emory University | Uses of jak inhibitors in the management of inflammation-associated depression and central nervous system (cns) pathologies |
| CN120152713A (zh) * | 2022-07-29 | 2025-06-13 | 昂胜医疗科技公司 | 三环芳基衍生物及其组合物和方法 |
| WO2025224600A1 (en) | 2024-04-21 | 2025-10-30 | Biohaven Therapeutics Ltd. | Treatment of alpha-synucleinopathies and neuroprotection |
| WO2025248468A1 (en) * | 2024-05-28 | 2025-12-04 | Biohaven Therapeutics Ltd. | Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria) |
| WO2026032213A1 (zh) * | 2024-08-08 | 2026-02-12 | 普罗思特(南京)生物科技有限公司 | 取代的三环衍生物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2473579B (en) * | 2008-06-30 | 2013-01-30 | Biotechnology Res Corp Ltd | Stat3 and TYK2 as drug targets for neurodegenerative diseases |
| CN105636962B (zh) * | 2013-10-15 | 2017-10-13 | 靳博涵 | 新型化合物、用途及其制备方法 |
| MX390005B (es) * | 2016-10-03 | 2025-03-20 | Hangzhou Highlightll Pharmaceutical Co Ltd | Inhibidores selectivos de jak1 novedosos y usos de los mismos. |
| BR112021024533A2 (pt) | 2019-06-06 | 2022-01-18 | Highlightll Pharmaceutical Hainan Co Ltd | Método de síntese de composto de furoimidazopiridina, forma cristalina de composto de furoimidazopiridina, e forma cristalina de sal do mesmo |
| WO2020244349A1 (zh) * | 2019-06-06 | 2020-12-10 | 广州高瓴制药有限公司 | 呋喃并咪唑并吡啶类化合物的合成方法、多晶型物、及盐的多晶型物 |
-
2022
- 2022-08-22 AU AU2022342095A patent/AU2022342095A1/en active Pending
- 2022-08-22 CN CN202280006751.7A patent/CN116490180B/zh active Active
- 2022-08-22 EP EP22866386.0A patent/EP4419101A4/en active Pending
- 2022-08-22 US US18/712,034 patent/US20250032465A1/en active Pending
- 2022-08-22 JP JP2024532463A patent/JP2024543198A/ja active Pending
- 2022-08-22 CA CA3239065A patent/CA3239065A1/en active Pending
- 2022-08-22 IL IL313097A patent/IL313097A/en unknown
- 2022-08-22 WO PCT/CN2022/113807 patent/WO2023035913A1/en not_active Ceased
- 2022-08-22 CN CN202410217414.3A patent/CN118059096A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024543198A5 (https=) | ||
| CN115190815B (zh) | 芳基环己基胺衍生物及其在精神障碍的治疗中的用途 | |
| KR100737090B1 (ko) | 축합 이미다졸륨 유도체 | |
| TWI538905B (zh) | 雙環［３．２．１］辛基醯胺衍生物及其用途 | |
| JP7470046B2 (ja) | ６－アミノイソキノリンのモノ酸塩及びその使用 | |
| AU2020206826B2 (en) | Ketamine pamoate and use thereof | |
| JP2009526831A5 (https=) | ||
| JP2021505575A (ja) | 非ラセミ混合物およびその使用 | |
| JP2010529969A5 (https=) | ||
| JP2023526050A (ja) | Ｅｎｐｐ１モジュレーターおよびその使用 | |
| JP2023507569A5 (https=) | ||
| JP2024540030A (ja) | 修飾インドール化合物 | |
| JP7264158B2 (ja) | 神経細胞内カルシウム濃度上昇抑制剤 | |
| CA2510514A1 (en) | Alpha-aminoamide derivatives useful as antimigraine agents | |
| JP5198293B2 (ja) | アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤 | |
| RU2019111188A (ru) | Кетоновые ингибиторы лизин-специфичного гингипаина | |
| CA2465691A1 (fr) | Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible | |
| KR100916160B1 (ko) | 약제학적 항암 조성물 | |
| JP2005517634A5 (https=) | ||
| JP2024506398A (ja) | Ｆｇｆ活性を調節するための方法及び組成物 | |
| CA2616177A1 (en) | Imidazolylalkyl-pyridines for the treatment of a sleep disorder | |
| RU2006105634A (ru) | Производные-аминоамидов, применимые в качестве противовоспалительных агентов | |
| JP2010529032A (ja) | 治療方法 | |
| JP2022515549A (ja) | パントテンアミドアナログ | |
| JP3634328B2 (ja) | 縮合イミダゾリウム誘導体を含む医薬組成物 |